John Overdeck’s Tenet Healthcare THC Stock Holding History

John Overdeck’s Portfolio THC Stock Details THC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$355K	Buy	+1,900	New	+$349K	﹤0.01%	4409
2022 Q1	–	Sell	-3,000	Closed	-$245K	–	4247
2021 Q4	$245K	Sell	3,000 -2,000	-40%	-$146K	﹤0.01%	3788
2021 Q3	$332K	Buy	+5,000	New	+$355K	﹤0.01%	3581
2020 Q4	–	Sell	-9,000	Closed	-$221K	–	3761
2020 Q3	$221K	Buy	+9,000	New	+$230K	﹤0.01%	2764
2020 Q1	–	Sell	-25,900	Closed	-$985K	–	3811
2019 Q4	$985K	Buy	25,900 +4,200	+19%	+$126K	﹤0.01%	2191
2019 Q3	$480K	Buy	+21,700	New	+$462K	﹤0.01%	2589
2018 Q3	–	Sell	-13,500	Closed	-$453K	–	3577
2018 Q2	$453K	Sell	13,500 -40,700	-75%	-$1.27M	﹤0.01%	2713
2018 Q1	$1.31M	Buy	54,200 +41,500	+327%	+$826K	﹤0.01%	1819
2017 Q4	$193K	Buy	+12,700	New	+$179K	﹤0.01%	2939
2017 Q3	–	Sell	-17,600	Closed	-$340K	–	3187
2017 Q2	$340K	Buy	+17,600	New	+$307K	﹤0.01%	2573
2016 Q4	–	Sell	-37,000	Closed	-$838K	–	3510
2016 Q3	$838K	Buy	37,000 +20,300	+122%	+$528K	﹤0.01%	2085
2016 Q2	$462K	Buy	16,700 +7,700	+86%	+$228K	﹤0.01%	2296
2016 Q1	$260K	Buy	+9,000	New	+$234K	﹤0.01%	2458

Other funds holding THC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GCM

Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

John Overdeck's THC Position: Q2 2026 in Review

John Overdeck reduced its Tenet Healthcare (THC) stake by 2.5% in Q2 2026, selling an estimated $186K and leaving 39,497 shares worth $7.39M. The position accounts for 0.01% of the portfolio, ranked #1777.

John Overdeck first reported a position in THC in Q2 2013 and has held it in 31 quarters since. The position peaked at $37.7M in Q4 2025. 673 funds tracked by Wall St. Rank hold THC as of Q2 2026.

John Overdeck held 39,497 shares of Tenet Healthcare worth $7.39M as of Q2 2026.
John Overdeck sold 1,009 Tenet Healthcare shares in Q2 2026, an estimated $186K.
Tenet Healthcare made up 0.01% of John Overdeck's portfolio in Q2 2026, its #1777 holding.
John Overdeck first reported a position in Tenet Healthcare in Q2 2013 and has held it in 31 quarters since.
John Overdeck's Tenet Healthcare position peaked at $37.7M in Q4 2025.
673 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.